Human red‐blood‐cell Ca2+‐antagonist binding sites
Open Access
- 1 July 1985
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 150 (1), 67-77
- https://doi.org/10.1111/j.1432-1033.1985.tb08989.x
Abstract
The human red blood cell ghost Ca2+-antagonist binding sites were characterized with (±)-[3H]nimodipine. The labelled 1,4-dihydropyridine bound in a non-cooperative, reversible manner with a Kd of 52 nM at 25°C to 9.65 pmol sites/mg ghost protein. The stereochemistry of the binding domain was evaluated with the optically pure enantiomers of chiral 1,4-dihydropyridines. In contrast to the 1,4-dihydropyridine-selective receptors on Ca2+ channels in electrically excitable tissues, the (+) enantiomer of nimodipine and the (−) enantiomer of the benzoxadiazol 1,4-dihydropyridine (PN 200–110) were bound with higher affinity than the respective optical antipodes. The human red blood cell ghost [3H]nimodipine-labelled sites also interacted with the inorganic Ca2+-antagonist La3+ (increase in the number of binding sites), and were allosterically regulated by the optical enantiomers of the phenylalkylamine-type Ca2+-antagonists (e.g. verapamil, desmethoxyverapamil, methoxyverapamil). The benzothiazepines d- or l-cis-diltiazem were without effect. Nucleosides (adenosine ∼ inosine > cytidine) were inhibitory at the nimodipine-labelled site, as were the nucleoside uptake inhibitors dipyridamole, hexobendine, dilazep, nitrobenzylthioinosine and nitrobenzylthioguanosine. The binding sites have essential sulfhydryl groups, show trypsin sensitivity, but are relatively heat stable. When nitrobenzylthioinosine was employed as a covalent probe to inactivate the red blood cell ghost nucleoside carrier, [3H]nimodipine binding was irreversibly lost. (+)-Nimodipine > (−)-nimodipine inhibited [14C]adenosine transport into human red blood cells. A good correlation between IC50 values for inhibition of [3H]nimodipine binding and IC50 values for inhibition of [14C]adenosine uptake was found for 18 compounds. Sheep red blood cells (which lack the nucleoside transporter) had no detectable [3H]nimodipine binding sites. It is concluded that the Ca2+-antagonist receptor sites of the human erythrocyte are coupled to the nucleoside transporter.This publication has 42 references indexed in Scilit:
- Nitrobenzylthioinosine binding in brain: An interspecies studyLife Sciences, 1985
- (—)‐[3H]Desmethoxyverapamil, a novel Ca2+ channel probeFEBS Letters, 1984
- Adenosine uptake sites in dog heart and brain; interaction with calcium antagonistsLife Sciences, 1984
- Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: Effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubulesBiochemical and Biophysical Research Communications, 1984
- Nitrendipine and isoproterenol induce phosphorylation of a 42,000 dalton protein that co-migrates with the affinity labeled calcium channel regulatory subunitBiochemical and Biophysical Research Communications, 1984
- Photoaffinity labelling of Ca2+ channels with [3H]azidopineFEBS Letters, 1984
- Temperature‐dependent regulation of d‐cis‐[3H]diltiazem binding to Ca2+ channels by 1,4‐dihydropyridine channel agonists and antagonistsFEBS Letters, 1983
- Target size analysis of skeletal muscle Ca2+ channelsFEBS Letters, 1983
- Identification of putative calcium channels in skeletal muscle microsomesFEBS Letters, 1982
- Nucleoside transport in mammalian cell membranesThe Journal of Membrane Biology, 1978